| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-05 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0004 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0005 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0007 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.0007 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |